1 |
NCT02445989 |
Recruiting |
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity |
|
|
Interventional |
Phase 4 |
- University of Washington
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Quantity of L. crispatus determined by species-specific qPCR assay
- Rates of bacterial vaginosis during contraceptive ring uses
- Number of adverse events with CVR use
- Acceptability of CVR to male sex partners of study participants assessed by questionnaire
|
120 |
Female |
18 Years to 40 Years (Adult) |
NCT02445989 |
48663 R01HD077872 |
|
May 2016 |
January 2018 |
January 2018 |
May 15, 2015 |
May 18, 2017 |
|
|
2 |
NCT00340275 |
Completed |
Longitudinal Study of Vaginal Flora |
|
|
Observational |
|
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institutes of Health Clinical Center (CC)
|
NIH |
|
|
5500 |
Female |
15 Years to 44 Years (Child, Adult) |
NCT00340275 |
999999023 OH99-CH-N023 |
|
April 14, 1999 |
|
November 18, 2010 |
June 21, 2006 |
July 2, 2017 |
|
- University of Alabama
Birmingham, Alabama, United States
|
3 |
NCT00542074 |
Completed |
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence |
|
- Other: hygienic information plus 62% ethyl alcohol in emollient gel
- Other: hygienic information
|
Interventional |
Not Applicable |
- University of Washington
- John E. Fogarty International Center (FIC)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute of Allergy and Infectious Diseases (NIAID)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- bacterial vaginosis by Nugent's score
- presence of lactobacillus by culture
|
223 |
All |
18 Years and older (Adult, Senior) |
NCT00542074 |
01-9276-001 R03TW005820 HD 40540-04 P30AI027757 |
|
June 2003 |
|
August 2005 |
October 10, 2007 |
October 31, 2007 |
|
- Nairobi City Council STI referral clinic (Special Treatment Clinic)
Nairobi, Kenya
|
4 |
NCT01322529 |
Completed |
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be |
- Pregnancy
- Pregnancy Complications
|
|
Observational |
|
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Heart, Lung, and Blood Institute (NHLBI)
- Office of Research on Women's Health (ORWH)
|
NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Adverse pregnancy outcome
- Preterm birth
- Spontaneous preterm birth
- (and 2 more...)
|
10038 |
Female |
13 Years and older (Child, Adult, Senior) |
NCT01322529 |
NICHD-nuMoM2b-001 1U10HD063036-01 1U10HD063072-01 1U10HD063047-01 1U10HD063037-01 1U10HD063041-01 1U10HD063020-01 1U10HD063046-01 1U10HD063048-01 1U10HD063053-01 |
nuMoM2b |
September 2010 |
May 2015 |
May 2015 |
March 24, 2011 |
January 12, 2016 |
|
- Fountain Valley Regional Hospital and Medical Center- UCI MFM private practice
Fountain Valley, California, United States - Long Beach Memorial Medical Center, Women's and Children's Hospital - Women's Perinatal Group, OB Clinic
Long Beach, California, United States - University of California, Irvine, Medical Center - Prenatal care clinics and private practice
Orange, California, United States - (and 14 more...)
|
5 |
NCT01986439 |
Unknown † |
The Contraceptive Choice Project |
- Unintended Pregnancy
- Teen Births
- Abortion
- Contraception
|
|
Observational |
|
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Distribution of contraceptive method chosen
- Method Continuation
- Method Satisfaction
- (and 3 more...)
|
9256 |
Female |
14 Years to 45 Years (Child, Adult) |
NCT01986439 |
201101982 |
|
August 2007 |
December 2016 |
December 2016 |
November 18, 2013 |
April 14, 2015 |
|
- Washington University in St. Louis School of Medicine
St. Louis, Missouri, United States
|
6 |
NCT01572532 |
Unknown † |
Maternal Genitourinary Infections and Adverse Perinatal Outcomes |
- Maternal Infection Affecting Newborn
|
- Other: Screening treatment and referral
|
Interventional |
Phase 3 |
- Johns Hopkins Bloomberg School of Public Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- United States Agency for International Development (USAID)
|
Other / NIH / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of preterm births reduced by community-based screening and treatment of abnormal vaginal flora and urinary tract infections in early pregnancy (13-19 weeks)
- Proportion of early outcomes
- Proportion of infants with neonatal sepsis
- (and 2 more...)
|
9000 |
All |
up to 47 Years (Child, Adult) |
NCT01572532 |
IRB00003063 1R01HD066156-01 |
|
August 2010 |
May 2015 |
May 2015 |
April 6, 2012 |
August 20, 2014 |
|
- Community Based
Sylhet, Bangladesh
|
7 |
NCT00070746 |
Completed |
Perinatal Infections in Pakistan |
- Bacterial Vaginosis
- Fetal Membranes, Premature Rupture
- Chorioamnionitis
- Pregnancy
|
|
Observational |
|
- NICHD Global Network for Women's and Children's Health
- Global Network for Women's and Children's Health Research
- Bill and Melinda Gates Foundation
- (and 7 more...)
|
Other / NIH |
- Time Perspective: Prospective
|
|
1500 |
Female |
Child, Adult, Senior |
NCT00070746 |
GN 09 U01HD040607 |
|
June 2003 |
|
July 2005 |
October 10, 2003 |
July 31, 2014 |
|
- Health clinic
Hyderabad, Pakistan
|
8 |
NCT00074425 |
Completed |
BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women |
|
- Drug: BufferGel
- Drug: PRO 2000/5 Gel
- Drug: Placebo gel
|
Interventional |
Phase 2 |
- National Institute of Allergy and Infectious Diseases (NIAID)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute on Drug Abuse (NIDA)
- (and 2 more...)
|
NIH / Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Safety of BufferGel and 0.5% PRO 2000/5 Gel (P), as assessed by deep epithelial disruption, other genital symptoms, or other systemic symptoms
- HIV infection as measured by seroconversion
- Bacterial vaginosis
- (and 11 more...)
|
3101 |
Female |
18 Years and older (Adult, Senior) |
NCT00074425 |
HPTN 035 10065 |
|
January 2005 |
September 2008 |
September 2008 |
December 15, 2003 |
July 11, 2013 |
|
- 3535 Market Street CRS
Philadelphia, Pennsylvania, United States - University of North Carolina Lilongwe CRS
Lilongwe, Central, Malawi - College of Med. JHU CRS
Blantyre, Southern, Malawi - (and 5 more...)
|
9 |
NCT01210040 |
Completed |
Long-term Iron Supplements and Malaria Risk in Early Pregnancy: a Randomized Controlled Trial |
|
- Dietary Supplement: Folic Acid
- Dietary Supplement: Folic Acid and Iron
|
Interventional |
Not Applicable |
- Liverpool School of Tropical Medicine
- Institute of Tropical Medicine, Belgium
- University of Manchester
- (and 4 more...)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Prevalence of peripheral parasitaemia at first antenatal clinic visit (13-16 weeks gestation)
- a) In the pregnant cohort: Prevalence of iron deficiency at first antenatal visit
- a) In the pregnant cohort: Prevalence of anaemia at first antenatal clinic visit
- (and 17 more...)
|
1959 |
Female |
15 Years to 24 Years (Child, Adult) |
NCT01210040 |
10.55 1U01HD061234-01A1 |
PALUFER |
April 2011 |
November 2013 |
January 2014 |
September 28, 2010 |
March 19, 2014 |
|
- Institute de Recherche en Sciences de la Sante, Direction Regionale de l'Ouest (IRSS-DRO) - / Centre Muraz
Bobo-Dioulasso 01, Burkina Faso
|